Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
Agency ▾
List of Bulk Drug Substances That May be Used to Compound Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations
Request that the FDA add a boxed warning to SSRIs to inform patients, providers, and the public that use of these medications during pregnancy has been shown to be associated with increased rates of pregnancy complications and alteration of fetal brain development
1 awaiting analysis
Using Relative Supersaturation to Support “Urinary Tract Health” Claims for Adult Maintenance Cat Food; Draft Guidance for Industry; Availability
Oral Drug Products Administered Via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations; Draft Guidance for Industry; Availability
2 awaiting analysis
Center for Biologics Evaluation and Research (CBER): COVID-19
2 awaiting analysis
Sean E. Rivera- Locomotive Engineer Certification
Requests that, within 180 days of the date of this Citizen Petition, the U.S. Food and Drug Administration (FDA or Agency): 1. Publish a notice in the Federal Register excluding liraglutide from the 503B Bulks List; 2. Rescind in its entirety the Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act (503B Interim Policy);
1 awaiting analysis
Notice of Establishment of the Motorcyclist Advisory Council (MAC) and Solicitation for Appointment to the MAC.
1 awaiting analysis
Requests that the FDA promulgate regulations for the standard of identity for olive oil and olive-pomace oil pursuant to Section 401 of the Federal Food, Drug, and Cosmetic Act.
3 awaiting analysis
Shell Docket for the Federal Motor Carrier Safety Administration (FMCSA)
2 awaiting analysis
Specific Electronic Submissions Intended for FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, and other administrative record submissions) - Comments/Complaints are not to be submitted on this docket ID.
1 awaiting analysis
Amazon - Exemption/Rulemaking
3 awaiting analysis